A first - in - human study of a new polymer - free drug - filled stent, which provides controlled drug
elution from an internal lumen, indicated non-inferior in - stent late lumen loss at nine - months compared with historical zotarolimus - eluting stent (Resolute) data.
The polymer - free drug - filled stent (DFS) used in the study was designed to provide controlled and sustained drug
elution from an internal stent lumen without a polymer coating.
Not exact matches
The filtered MS / MS peptide identifications obtained
from the 2D - LC - MS / MS analyses of all pooled CSF samples were included in an AMT tag database with their theoretical mass and normalized
elution time (NET;
from 0 to 1) recorded.
In vitro
elution of amikacin and vancomycin
from impregnated plaster of Paris beads.